Physician
Midstate Gastroenterology Specialists PC
Midstate Gastroenterology Specialists PC was paid $6.61M by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 20% of everything it billed.
33Billing provider infoMIDSTATE GASTROENTEROLOGY SPECIALISTS PC
MERIDEN, CT 06451
MERIDEN, CT 06451
33aNPI1487677951assigned 07/25/2006
33bProvider typeGastroenterology Physician
28Total paid$6.61M
24GClaims99,571
24DCodes billed34
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Gastroenterology Physician providers in Connecticut
Rank by total paid#2 of 19
Median peer was paid$164K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,286 | $333K | |
| 2019 | 12,875 | $708K | |
| 2020 | 13,100 | $973K | |
| 2021 | 15,191 | $1.11M | |
| 2022 | 16,358 | $1.15M | |
| 2023 | 18,269 | $1.22M | |
| 2024incomplete | 16,492 | $1.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 30,884 | 25,865 | $1.34M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18% | 7,496 | 7,084 | $1.19M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 10,860 | 9,388 | $667K |
| 88313 | 8.4% | 5,618 | 5,384 | $553K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 8.1% | 5,644 | 5,166 | $536K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 7.5% | 10,172 | 9,262 | $499K |
| 88312 | 5.8% | 5,563 | 5,345 | $382K | |
| 99243 | 4.5% | 3,627 | 3,434 | $296K | |
| 00813 | 3.2% | 2,901 | 2,772 | $211K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.9% | 3,360 | 2,889 | $195K |
| 46221 | 2.8% | 2,193 | 1,475 | $184K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.0% | 1,655 | 1,440 | $135K |
22 more codes
| 00731 | 2.0% | 2,239 | $131K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.6% | 1,017 | $106K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 465 | $53K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 471 | $42K |
| 00811 | <1% | 442 | $25K | |
| 96415 | <1% | 1,066 | $19K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 307 | $15K |
| 00812 | <1% | 251 | $14K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 87 | $9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 325 | $3K |
| 99253 | <1% | 43 | $2K | |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | <1% | 360 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 68 | $2K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 90 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 305 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 20 | $1K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,547 | $753.68 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 90 | $692.99 |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 18 | $557.60 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $539.76 |
| 99442 | <1% | 14 | $521.12 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 361 | $128.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSACK, DAVID (PRESIDENT)